Nova Eye Medical Limited (EYE.AX)
AUD 0.16
(0.0%)
AUD 0.16
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -2.8 Million AUD | 52.41% |
| 2023 | -5.88 Million AUD | 2.79% |
| 2022 | -6.05 Million AUD | 57.05% |
| 2021 | -14.1 Million AUD | 84.72% |
| 2020 | -92.3 Million AUD | -31620.62% |
| 2019 | -291 Thousand AUD | 96.39% |
| 2018 | -8.06 Million AUD | -226.24% |
| 2017 | 6.39 Million AUD | 621.33% |
| 2016 | 886 Thousand AUD | -59.06% |
| 2015 | 2.16 Million AUD | -45.55% |
| 2014 | 3.97 Million AUD | -39.34% |
| 2013 | 6.55 Million AUD | 9.07% |
| 2012 | 6 Million AUD | -10.25% |
| 2011 | 6.69 Million AUD | 7.11% |
| 2010 | 6.24 Million AUD | -29.43% |
| 2009 | 8.85 Million AUD | -8.96% |
| 2008 | 9.72 Million AUD | 169.32% |
| 2007 | 3.61 Million AUD | 51.28% |
| 2006 | 2.38 Million AUD | -56.39% |
| 2005 | 5.47 Million AUD | 269.55% |
| 2004 | 1.48 Million AUD | 34.51% |
| 2003 | 1.1 Million AUD | -41.37% |
| 2002 | 1.87 Million AUD | 599.47% |
| 2001 | -376 Thousand AUD | -88.0% |
| 2000 | -200 Thousand AUD | 6.54% |
| 1999 | -214 Thousand AUD | 66.25% |
| 1998 | -634 Thousand AUD | -85.92% |
| 1997 | -341 Thousand AUD | -20.11% |
| 1996 | -283.91 Thousand AUD | 72.99% |
| 1995 | -1.05 Million AUD | -1136.47% |
| 1994 | -85 Thousand AUD | 57.92% |
| 1993 | -202 Thousand AUD | 29.62% |
| 1992 | -287 Thousand AUD | -1204.55% |
| 1991 | -22 Thousand AUD | -130.56% |
| 1990 | 72 Thousand AUD | 137.89% |
| 1989 | -190 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -2.8 Million AUD | 0.0% |
| 2024 Q2 | -1.39 Million AUD | 0.0% |
| 2024 FY | -2.8 Million AUD | 52.41% |
| 2023 Q4 | -5.88 Million AUD | 0.0% |
| 2023 FY | -5.88 Million AUD | 2.79% |
| 2023 Q2 | -817 Thousand AUD | 0.0% |
| 2022 Q2 | -11.38 Million AUD | 0.0% |
| 2022 FY | -6.05 Million AUD | 57.05% |
| 2022 Q4 | -6.05 Million AUD | 0.0% |
| 2021 Q2 | -26.16 Million AUD | 0.0% |
| 2021 FY | -14.1 Million AUD | 84.72% |
| 2021 Q4 | -14.1 Million AUD | 0.0% |
| 2020 Q4 | -92.3 Million AUD | 0.0% |
| 2020 Q2 | 1.22 Million AUD | 0.0% |
| 2020 FY | -92.3 Million AUD | -31620.62% |
| 2019 Q4 | -291 Thousand AUD | 0.0% |
| 2019 Q2 | -4.35 Million AUD | 0.0% |
| 2019 FY | -291 Thousand AUD | 96.39% |
| 2018 FY | -8.06 Million AUD | -226.24% |
| 2018 Q4 | -8.06 Million AUD | 0.0% |
| 2018 Q2 | -9.74 Million AUD | 0.0% |
| 2017 FY | 6.39 Million AUD | 621.33% |
| 2017 Q2 | -3.47 Million AUD | 0.0% |
| 2017 Q4 | 6.39 Million AUD | 0.0% |
| 2016 Q4 | 886 Thousand AUD | 0.0% |
| 2016 FY | 886 Thousand AUD | -59.06% |
| 2016 Q2 | 987 Thousand AUD | 0.0% |
| 2015 FY | 2.16 Million AUD | -45.55% |
| 2015 Q4 | 2.16 Million AUD | 0.0% |
| 2015 Q2 | 2.47 Million AUD | 0.0% |
| 2014 Q2 | 2.54 Million AUD | 0.0% |
| 2014 Q4 | 3.97 Million AUD | 0.0% |
| 2014 FY | 3.97 Million AUD | -39.34% |
| 2013 Q4 | 6.55 Million AUD | 0.0% |
| 2013 FY | 6.55 Million AUD | 9.07% |
| 2013 Q2 | -1.27 Million AUD | 0.0% |
| 2012 FY | 6 Million AUD | -10.25% |
| 2012 Q4 | 6 Million AUD | 0.0% |
| 2011 Q4 | 6.73 Million AUD | 0.0% |
| 2011 FY | 6.69 Million AUD | 7.11% |
| 2010 FY | 6.24 Million AUD | -29.43% |
| 2010 Q4 | 6.24 Million AUD | 0.0% |
| 2009 Q4 | 8.85 Million AUD | 0.0% |
| 2009 FY | 8.85 Million AUD | -8.96% |
| 2008 Q4 | 9.72 Million AUD | 0.0% |
| 2008 FY | 9.72 Million AUD | 169.32% |
| 2007 FY | 3.61 Million AUD | 51.28% |
| 2007 Q4 | 3.61 Million AUD | 0.0% |
| 2006 FY | 2.38 Million AUD | -56.39% |
| 2006 Q4 | 2.38 Million AUD | 0.0% |
| 2005 Q4 | 5.47 Million AUD | 0.0% |
| 2005 FY | 5.47 Million AUD | 269.55% |
| 2004 Q4 | 1.48 Million AUD | 0.0% |
| 2004 FY | 1.48 Million AUD | 34.51% |
| 2003 Q4 | 1.1 Million AUD | 0.0% |
| 2003 FY | 1.1 Million AUD | -41.37% |
| 2002 FY | 1.87 Million AUD | 599.47% |
| 2002 Q4 | 1.87 Million AUD | 0.0% |
| 2001 Q4 | -375.66 Thousand AUD | 0.0% |
| 2001 FY | -376 Thousand AUD | -88.0% |
| 2000 Q4 | -200.32 Thousand AUD | 0.0% |
| 2000 FY | -200 Thousand AUD | 6.54% |
| 1999 Q4 | -214.16 Thousand AUD | 0.0% |
| 1999 FY | -214 Thousand AUD | 66.25% |
| 1998 Q4 | -647.92 Thousand AUD | 0.0% |
| 1998 FY | -634 Thousand AUD | -85.92% |
| 1997 Q4 | -340.76 Thousand AUD | 0.0% |
| 1997 FY | -341 Thousand AUD | -20.11% |
| 1996 FY | -283.91 Thousand AUD | 72.99% |
| 1995 FY | -1.05 Million AUD | -1136.47% |
| 1994 FY | -85 Thousand AUD | 57.92% |
| 1993 FY | -202 Thousand AUD | 29.62% |
| 1992 FY | -287 Thousand AUD | -1204.55% |
| 1991 FY | -22 Thousand AUD | -130.56% |
| 1990 FY | 72 Thousand AUD | 137.89% |
| 1989 FY | -190 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 89.006% |
| Adherium Limited | -6.1 Million AUD | 54.098% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 25.223% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 22.238% |
| Anteris Technologies Ltd | -28.49 Million AUD | 90.168% |
| Control Bionics Limited | -19.02 Thousand AUD | -14630.312% |
| CardieX Limited | 2.74 Million AUD | 202.027% |
| Compumedics Limited | 5.08 Million AUD | 155.082% |
| Cochlear Limited | -269.9 Million AUD | 98.962% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 501.092% |
| Cyclopharm Limited | -7.49 Million AUD | 62.636% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 82.154% |
| HeraMED Limited | -799.34 Thousand AUD | -250.536% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 119.347% |
| ImpediMed Limited | -23.48 Million AUD | 88.071% |
| InhaleRx Limited | -155.54 Thousand AUD | -1701.42% |
| LBT Innovations Limited | -604 Thousand AUD | -363.907% |
| Micro-X Limited | 826.99 Thousand AUD | 438.815% |
| Neurotech International Limited | -2.11 Million AUD | -32.766% |
| OncoSil Medical Limited | -4.43 Million AUD | 36.76% |
| PolyNovo Limited | -30.52 Million AUD | 90.821% |
| Respiri Limited | 413.68 Thousand AUD | 777.32% |
| SomnoMed Limited | -15.16 Million AUD | 81.521% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 47.171% |
| Uscom Limited | -1.53 Million AUD | -83.062% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 31.373% |